Nerdwallet, Inc.: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Oct 26, 2023 and accepted by EDGAR at Oct 26, 2023, 16:45 ET.
Management's discussion and analysis
As filed, 35,249 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited interim condensed consolidated financial statements and related notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q, and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.
Overview
Our mission is to provide clarity for all of life’s financial decisions.
Our vision is a world where everyone makes financial decisions with confidence.
As a personal finance website and app, NerdWallet provides consumers with trustworthy and knowledgeable financial information so they can make smart money moves. From finding the best credit card to buying a house, NerdWallet is there to help consumers make financial decisions with confidence. Consumers have free access to our expert content and comparison shopping marketplaces, plus a data-driven app, which helps them stay on top of their finances and save time and money, giving them the freedom to do more. NerdWallet is available for consumers in the U.S., United Kingdom, Canada and Australia.
Acquisition of On the Barrelhead, Inc.
On July 11, 2022, we completed the acquisition of On the Barrelhead, Inc. (OTB), a data-driven platform that provides consumers and small and mid-sized businesses (SMBs) with credit-driven product recommendations. See Note 5—Business Combination in the notes to our condensed consolidated financial statements, and Note 5—Business Combinations in the notes to our consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022, for further discussion.
Key Operating Metric and Non-GAAP Financial Measure
We collect, review and analyze operating and financial data of our business to assess our ongoing performance and compare our results to prior period results. In addition to revenue, net income (loss) and other results under generally accepted accounting principles (GAAP), the following sets forth the key operating metric we use to evaluate our business.
Monthly Unique Users
We define a Monthly Unique User (MUU) as a unique user with at least one session in a given month as determined by a unique device identifier. We measure MUUs during a time period longer than one month by averaging the MUUs of each month within that period. We track MUUs to frame the number of users who may transact with our financial services partners on our platform during a given period. We had 24 million and 23 million average MUUs for the three and nine months ended September 30, 2023, which was up 22% and 12% compared to the three and nine months ended September 30, 2022, respectively. We saw strong engagement in areas such as travel products, banking and insurance, and are also incorporating our acquisition of OTB in July 2022. Partially offsetting growth were declines from a continued challenging macroeconomic environment in mortgages. While we expect MUUs to grow over time, the metric may fluctuate from period to period based on economic conditions, trends in consumer behavior, and our strategic marketing decisions.
Adjusted EBITDA
We use Adjusted EBITDA in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our Board of Directors concerning our financial performance.
We define Adjusted EBITDA as net income (loss) from continuing operations adjusted to exclude depreciation and amortization, interest income (expense), net, provision (benefit) for income taxes, and further exclude (1) losses (gains) on disposals of assets, (2) change in fair value of contingent consideration related to earnouts, (3) deferred compensation related to earnouts, (4) stock-based compensation, and (5) acquisition-related costs.
The above items are excluded from our Adjusted EBITDA measure because these items are non-cash in nature, or because the amount is not driven by core operating results and renders comparisons with prior periods less meaningful.
We believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results and in comparing operating results across periods. Moreover, we have included Adjusted EBITDA in this Quarterly Report on Form 10-Q because it is a key measurement used by our management internally to make operating decisions, including those related to analyzing operating expenses, evaluating performance, and performing strategic planning and annual budgeting. However, the use of this non-GAAP measure has certain limitations because it does not reflect all items of income and expense that affect our operations. Adjusted EBITDA has limitations as a financial measure, should be considered as supplemental in nature, and is not meant as a substitute for the related financial information prepared in accordance with GAAP. These limitations include the following:
- Adjusted EBITDA does not reflect interest income (expense) and other gains (losses), net, which include unrealized and realized gains and losses on foreign currency exchange, as well as certain nonrecurring gains (losses);
- Adjusted EBITDA excludes certain recurring, non-cash charges, such as amortization of software, depreciation of property and equipment, amortization of intangible assets, and (losses) gains on disposals of assets. Although these are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect all cash requirements for such replacements or for new capital expenditure requirements;
- Adjusted EBITDA excludes stock-based compensation, including for acquisition-related inducement awards, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy; and
- Adjusted EBITDA excludes acquisition-related costs, including acquisition-related retention compensation under compensatory retention agreements with certain key employees, acquisition-related transaction expenses, contingent consideration fair value adjustments related to earnouts, and deferred compensation related to earnouts.
In addition, Adjusted EBITDA as we define it may not be comparable to similarly titled measures used by other companies. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including net income (loss) and our other GAAP results.
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Results of Operations—Non-GAAP Financial Measure” for a reconciliation of Adjusted EBITDA to net income (loss), the most directly comparable financial measure calculated in accordance with GAAP.
Results of Operations
The following tables set forth our results of operations for the periods presented. The following discussion should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q.
(in millions)
| Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $152.8 | $142.6 | $465.7 | $396.9 |
| Costs and expenses: | ||||
| Cost of revenue | 13.3 | 11.7 | 40.2 | 27.6 |
| Research and development1 | 20.7 | 20.7 | 60.2 | 58.2 |
| Sales and marketing1 | 100.6 | 103.2 | 321.1 | 288.1 |
| General and administrative1 | 14.2 | 15.4 | 45.2 | 43.8 |
| Change in fair value of contingent consideration related to earnouts | — | 0.4 | — | 6.1 |
| Total costs and expenses | 148.8 | 151.4 | 466.7 | 423.8 |
| Income (loss) from operations | 4.0 | (8.8) | (1.0) | (26.9) |
| Other income (expense), net: | ||||
| Interest income | 0.9 | 0.5 | 2.7 | 0.6 |
| Interest expense | (0.2) | (0.9) | (0.6) | (1.3) |
| Other losses, net | — | — | (0.1) | — |
| Total other income (expense), net | 0.7 | (0.4) | 2.0 | (0.7) |
| Income (loss) before income taxes | 4.7 | (9.2) | 1.0 | (27.6) |
| Income tax provision (benefit) | 5.2 | (9.9) | 10.5 | (8.5) |
| Net income (loss) | $(0.5) | $0.7 | $(9.5) | $(19.1) |
(1) Includes stock-based compensation as follows:
(in millions)
| Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|---|---|
| Research and development | $2.9 | $2.8 | $8.4 | $9.0 |
| Sales and marketing | 3.5 | 3.4 | 10.7 | 9.1 |
| General and administrative | 3.0 | 2.9 | 10.2 | 7.2 |
| Total stock-based compensation | $9.4 | $9.1 | $29.3 | $25.3 |
19
The following table sets forth the components of our condensed consolidated statements of operations as a percentage of revenue:
| Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | 100% | 100% | 100% | 100% |
| Costs and expenses: | ||||
| Cost of revenue | 9 | 8 | 8 | 7 |
| Research and development | 13 | 15 | 13 | 15 |
| Sales and marketing | 66 | 72 | 69 | 73 |
| General and administrative | 9 | 11 | 10 | 11 |
| Change in fair value of contingent consideration related to earnouts | — | — | — | 1 |
| Total costs and expenses | 97 | 106 | 100 | 107 |
| Income (loss) from operations | 3 | (6) | — | (7) |
| Other income (expense), net: | ||||
| Interest income | — | — | — | — |
| Interest expense | — | — | — | — |
| Other losses, net | — | — | — | — |
| Total other income (expense), net | — | — | — | — |
| Income (loss) before income taxes | 3 | (6) | — | (7) |
| Income tax provision (benefit) | 3 | (7) | 2 | (2) |
| Net income (loss) | —% | 1% | (2%) | (5%) |
We had a net loss of $0.5 million for the three months ended September 30, 2023, as compared to net income of $0.7 million for the three months ended September 30, 2022, while net loss decreased $9.6 million, or 50%, for the nine months ended September 30, 2023 as compared to the nine months ended September 30, 2022. Revenues increased by $10.2 million and $68.8 million, respectively, for the three and nine months ended September 30, 2023. Expenses decreased by $2.6 million for the three months ended September 30, 2023 primarily due to a $2.6 million decrease in sales and marketing expense, and increased $42.9 million for the nine months ended September 30, 2023 primarily driven by increases of $33.0 million in sales and marketing expense and $12.6 million in cost of revenue, partially offset by a $6.1 million decrease for changes in fair value of contingent consideration related to earnouts. Additionally, we had increases of $15.1 million and $19.0 million in income tax provisions for the three and nine months ended September 30, 2023, respectively.
Revenue
(in millions)
| Three Months Ended September 30, 2023 | 2022 | Change $% | Nine Months Ended September 30, 2023 | 2022 | Change $% | |||
|---|---|---|---|---|---|---|---|---|
| Credit cards | $54.0 | $57.4 | $(3.4) | (6%) | $166.5 | $157.2 | $9.3 | 6% |
| Loans | 32.9 | 28.4 | 4.5 | 16% | 78.0 | 86.7 | (8.7) | (10%) |
| Other verticals | 65.9 | 56.8 | 9.1 | 16% | 221.2 | 153.0 | 68.2 | 45% |
| Total revenue | $152.8 | $142.6 | $10.2 | 7% | $465.7 | $396.9 | $68.8 | 17% |
Revenue increased $10.2 million, or 7% and $68.8 million, or 17%, for the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022, respectively, primarily driven by strong growth in other verticals revenues.
Credit cards revenue decreased $3.4 million, or 6%, for the three months ended September 30, 2023, primarily due to reduced marketing spending by our financial services partners amidst a combination of increasingly cautious underwriting and heightened balance sheet conservatism following the regional banking crisis. Credit cards revenue increased $9.3 million, or 6%, for the nine months ended September 30, 2023, reflecting our ability to capitalize on higher consumer intent through improved user experiences combined with our deep alignment with our financial services partners to deliver quality matches.
Loans revenue increased $4.5 million, or 16%, for the three months ended September 30, 2023, primarily due to a 51% increase in personal loans revenue reflecting continued integration and optimization of our acquisition of OTB in July 2022, partially offset by a 33% decrease in mortgages revenue driven by higher interest rates and continuing macroeconomic headwinds. Loans revenue decreased $8.7 million, or 10%, for the nine months ended September 30, 2023, primarily due to decreases of 45% in mortgages revenue and 24% in student loans, partially offset by a 33% increase in personal loans.
Other verticals revenue increased $9.1 million, or 16%, and $68.2 million, or 45%, for the three and nine months ended September 30, 2023, respectively, driven by increases of 43% and 115%, respectively, in banking revenue primarily due to the higher interest rate environment, and 6% and 12%, respectively, in SMB products revenue. Additionally, insurance revenue decreased 23% for the three months ended September 30, 2023 reflecting inflation-driven profitability pressure on carriers, and increased 51% for the nine months ended September 30, 2023 primarily driven by auto insurance.
Costs and Expenses
(in millions)
| Three Months Ended September 30, 2023 | 2022 | Change $% | Nine Months Ended September 30, 2023 | 2022 | Change $% | |||
|---|---|---|---|---|---|---|---|---|
| Cost of revenue | $13.3 | $11.7 | $1.6 | 13% | $40.2 | $27.6 | $12.6 | 46% |
| Research and development | 20.7 | 20.7 | — | 0% | 60.2 | 58.2 | 2.0 | 3% |
| Sales and marketing | 100.6 | 103.2 | (2.6) | (2%) | 321.1 | 288.1 | 33.0 | 11% |
| General and administrative | 14.2 | 15.4 | (1.2) | (9%) | 45.2 | 43.8 | 1.4 | 3% |
| Change in fair value of contingent consideration related to earnouts | — | 0.4 | (0.4) | (100%) | — | 6.1 | (6.1) | (100%) |
| Total costs and expenses | $148.8 | $151.4 | $(2.6) | (2%) | $466.7 | $423.8 | $42.9 | 10% |
Cost of revenue
Cost of revenue increased $1.6 million, or 13%, and $12.6 million, or 46%, for the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022, respectively, attributable to increases of $1.4 million and $9.6 million, respectively, in amortization expense related to capitalized software development costs and intangible assets from our acquisition of OTB in July 2022. The increase for the nine months ended September 30, 2023 also included a $1.9 million increase primarily related to third-party service charges.
Research and development expense
Research and development expenses were comparable for the three months ended September 30, 2023 and increased $2.0 million, or 3%, for the nine months ended September 30, 2023, as compared to the three and nine months ended September 30, 2022, respectively. The increase for the nine months ended September 30, 2023 was primarily attributable to a $1.5 million increase in software and technology costs related to our platform.
Sales and marketing expense
For the three and nine months ended September 30, 2023, our total sales and marketing expense was comprised of approximately 19% and 24% for brand marketing, respectively, and 53% and 49% for performance marketing, respectively, with the remainder for organic and other marketing expenses. For the three and nine months ended September 30, 2022, our total sales and marketing expense was comprised of approximately 27% and 33% for brand marketing, respectively, and 46% and 41% for performance marketing, respectively, with the remainder for organic and other marketing expenses. We are able to adjust our marketing spend to reflect changes in external factors and consumer behavior.
Sales and marketing expenses decreased $2.6 million, or 2%, for the three months ended September 30, 2023 as compared to the three months ended September 30, 2022, primarily attributable to an $8.6 million decrease in brand marketing expenses, partially offset by a $5.6 million increase in performance marketing expenses. Sales and marketing expenses increased $33.0 million, or 11%, for the nine months ended September 30, 2023 as compared to the nine months ended September 30, 2022, primarily attributable to increases of $39.6 million in performance marketing expenses and $10.1 million in organic and other marketing expenses primarily due to higher personnel-related costs due to our efforts to grow and increase our user base, partially offset by a $16.7 million decrease in brand marketing expenses.
General and administrative expense
General and administrative expenses decreased $1.2 million, or 9%, for the three months ended September 30, 2023 and increased $1.4 million, or 3%, for the nine months ended September 30, 2023, as compared to the three and nine months ended September 30, 2022, respectively. The changes were primarily attributable to the impacts of increases of $0.6 million and $4.9 million, respectively, in personnel-related costs mainly due to higher stock-based compensation and increased headcount, offset by decreases of $0.9 million and $2.9 million, respectively, of acquisition-related costs primarily related to our acquisition of OTB in July 2022, and $0.6 million and $0.7 million, respectively, primarily related to director and officer liability insurance costs.
Change in fair value of contingent consideration related to earnouts
The change in fair value of contingent consideration relates to our acquisitions of Fundera, Inc. (Fundera) and Know Your Money (KYM) in 2020. The fair value of the estimated contingent considerations was subject to remeasurement at each reporting date until the payments were made. See Note 3–Fair Value Measurements in the notes to our condensed consolidated financial statements for further discussion on these contingent considerations.
Other income (expense), net
(in millions)
| Three Months Ended September 30, 2023 | 2022 | Change $% | Nine Months Ended September 30, 2023 | 2022 | Change $% | |||
|---|---|---|---|---|---|---|---|---|
| Interest income | $0.9 | $0.5 | $0.4 | 75% | $2.7 | $0.6 | $2.1 | 354% |
| Interest expense | (0.2) | (0.9) | 0.7 | (77%) | (0.6) | (1.3) | 0.7 | (54%) |
| Other losses, net | — | — | — | NM | (0.1) | — | (0.1) | 226% |
| Total other income (expense), net | $0.7 | $(0.4) | $1.1 | NM | $2.0 | $(0.7) | $2.7 | NM |
The change in other income (expense), net for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 30, 2022 was primarily attributable to higher interest income and lower interest expense.
Income tax provision (benefit)
Beginning with the three months ended June 30, 2023, our tax provision for interim periods was determined using a discrete effective tax rate method, as allowed by ASC Topic 740-270, Income Taxes, Interim Reporting. Our tax provision for interim periods was previously determined using an estimated annual effective tax rate which was adjusted for discrete items occurring during the periods presented. We determined that since small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, the historical method would not provide a reliable estimate for the three months ended September 30, 2023.
We had income tax provisions of $5.2 million and $10.5 million for the three and nine months ended September 30, 2023, respectively, as compared to income tax benefits of $9.9 million and $8.5 million for the three and nine months ended September 30, 2022, respectively. Our effective tax rate was 110.9% and 1,080.6% for the three and nine months ended September 30, 2023, and 107.5% and 30.9% three and nine months ended September 30, 2022, respectively. Our effective tax rate for the three and nine months ended September 30, 2023 differs from the U.S. federal statutory income tax rate of 21% primarily due to capitalization of research and development expenses under tax regulations effective in 2022, a full valuation allowance recorded against our net U.S. deferred tax assets, and excess tax benefits related to stock based compensation. During the three and nine months ended September 30, 2022, we recognized a tax benefit of $12.1 million related to the change in the Company’s existing full valuation allowance on deferred tax assets resulting from our acquisition of OTB in July 2022, partially offset by higher capitalization of research and development expenses under new tax regulations effective in 2022.
Non-GAAP Financial Measure
Adjusted EBITDA as we define it may not be comparable to similarly titled measures used by other companies. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including net income (loss) and our other GAAP results.
We compensate for these limitations by reconciling Adjusted EBITDA to net income (loss), the most comparable GAAP financial measure, as follows:
(in millions)
| Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|---|---|
| Net income (loss) | $(0.5) | $0.7 | $(9.5) | $(19.1) |
| Depreciation and amortization | 12.1 | 10.8 | 36.0 | 25.6 |
| Stock-based compensation | 9.4 | 9.1 | 29.3 | 25.3 |
| Acquisition-related retention | 1.2 | 1.4 | 4.0 | 1.4 |
| Deferred compensation related to earnouts | — | 0.4 | — | 1.2 |
| Change in fair value of contingent consideration related to earnouts | — | 0.4 | — | 6.1 |
| Acquisition-related expenses | — | 1.2 | — | 3.4 |
| Interest (income) expense, net | (0.7) | 0.4 | (2.1) | 0.7 |
| Other losses, net | — | — | 0.1 | — |
| Income tax provision (benefit) | 5.2 | (9.9) | 10.5 | (8.5) |
| Adjusted EBITDA | $26.7 | $14.5 | $68.3 | $36.1 |
| Net income (loss) margin | 0% | 0% | (2%) | (5%) |
| Adjusted EBITDA margin1 | 18% | 10% | 15% | 9% |
(1) Represents Adjusted EBITDA as a percentage of revenue.
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Results of Operations” for a discussion of the changes in net income (loss) for the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022.
Adjusted EBITDA increased $12.2 million and $32.2 million for the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022, respectively. The increases were primarily attributable to increases in adjustments to reconcile Adjusted EBITDA to net income (loss), including $1.3 million and $10.4 million for depreciation and amortization, and $15.1 million and $19.0 million for income taxes, partially offset by decreases of $1.2 million and $3.4 million for acquisition-related expenses, and $1.1 million and $2.8 million for interest income (expense), net. Additionally, the increase in Adjusted EBITDA for the nine months ended September 30, 2023 includes a $9.6 million decrease in net loss and increases of $4.0 million for stock-based compensation and $2.6 million for acquisition-related retention, partially offset by a $6.1 million decrease for the change in fair value of contingent consideration related to earnouts.
Liquidity and Capital Resources
Overview
Our principal sources of liquidity to meet our business requirements and plans, both in the short-term (i.e., the next twelve months from September 30, 2023) and long-term (i.e., beyond the next twelve months), have historically been cash generated from operations and, more recently, sales of our common stock, and borrowings under our credit facilities. Our primary liquidity needs are related to the funding of general corporate requirements, including working capital, research and development, and capital expenditures, as well as other liquidity requirements including, but not limited to, business combinations.
As of September 30, 2023 and December 31, 2022, we had cash and cash equivalents of $86.6 million and $83.9 million, respectively.
Known Contractual and Other Obligations
A description of contractual commitments as of September 30, 2023 is included in Note 7–Commitments and Contingencies in the notes to our condensed consolidated financial statements.
More broadly, we also have purchase obligations under contractual arrangements with vendors and service providers, including for certain web-hosting and cloud computing services, which do not qualify for recognition on our condensed consolidated balance sheets but which we consider non-cancellable. During the nine months ended September 30, 2023, there have been no material changes in our purchase obligations as disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Capital Resources” in our Annual Report on Form 10-K for the year ended December 31, 2022.
In addition, as part of the acquisitions of KYM and Fundera, both in 2020, we committed to pay additional amounts of up to $11 million and $66 million, respectively, related to contingent earnout consideration over the succeeding years based, in part, on the achievement of certain financial metrics related to 2021 and 2022. As of December 31, 2022, Fundera’s revenue and profitability milestones for 2022 were achieved and the contingent consideration liability was recorded at the full payout amount of $30.9 million (see Note 3–Fair Value Measurements in the notes to our condensed consolidated financial statements). During the nine months ended September 30, 2023, we paid $32.6 million for the 2022 performance period, consisting of $30.9 million of contingent consideration and the remainder for deferred compensation related to earnouts.
Trends, Uncertainties and Anticipated Sources of Funds
In order to grow our business, we expect to increase our personnel and related expenses and to make significant investments in our business. The timing and amount of these investments will vary based on our financial condition, the rate at which we add new personnel and the scale of our development, as well as the macroeconomic environment. Many of these investments will occur in advance of our experiencing any direct benefit from them, which could negatively impact our liquidity and cash flows during any particular period and may make it difficult to determine if we are effectively allocating our resources. However, we expect to fund our operations, capital expenditures and other investments principally with cash flows from operations, and to the extent that our liquidity needs exceed our cash from operations, we would look to our cash on hand to satisfy those needs.
On May 2, 2023, we announced that our Board of Directors authorized a plan (the Repurchase Plan) under which we may repurchase up to $20 million of our Class A common stock. Subject to market conditions and other factors, the Repurchase Plan is intended to make opportunistic repurchases of our Class A common stock to reduce our outstanding share count. Under the Repurchase Plan, shares of Class A common stock may be repurchased in the open market through privately negotiated transactions or otherwise, in accordance with applicable securities laws and other restrictions. The Repurchase Plan does not have a fixed expiration date and does not obligate us to acquire any specific number of shares. The timing and terms of any repurchases under the Repurchase Plan are at management’s discretion and depend on a variety of factors, including business, economic and market conditions, regulatory requirements, prevailing stock prices and other considerations. Additionally, we may, from time to time, enter into Rule 10b-5 trading plans to facilitate repurchases. Shares repurchased under the Repurchase Plan are retired. We expect to fund repurchases with existing cash and cash equivalents. During the nine months ended September 30, 2023, we repurchased 1.3 million shares of Class A common stock for $12.1 million, including costs associated with the repurchases.
We believe our current cash and cash equivalents and future cash flow from operations, as well as access to our credit facility with JPMorgan Chase Bank and a syndicate of other lenders, subject to customary borrowing conditions, will be sufficient to meet our ongoing working capital, capital expenditure and other liquidity requirements for at least twelve months from the date of this filing.
On September 26, 2023, we, including three of our wholly-owned subsidiaries, entered into a credit agreement (the Credit Agreement) with JPMorgan Chase Bank, National Association. as Administrative Agent, and a syndicate of lenders. The Credit Agreement provides for a $125.0 million senior secured revolving credit facility (the Credit Facility), with the option to increase up to an additional $75.0 million, and is available to be used by us and certain of our domestic subsidiaries for general corporate purposes, including acquisitions. The Credit Facility matures on September 26, 2028. See Note 6–Debt in the notes to our condensed consolidated financial statements for further discussion.
The Credit Facility replaces our prior credit facility under the Amended and Restated Senior Secured Credit Facilities Credit Agreement dated February 19, 2021 between us and Silicon Valley Bank, as administrative agent (the Prior Credit Agreement), which was terminated substantially concurrently with the Company’s entering into the Credit Agreement. Under the terms of our Prior Credit Agreement, we could have borrowed up to $100.0 million, subject to borrowing conditions.
We had no outstanding balance on our credit facilities at September 30, 2023 or December 31, 2022. The available amounts to borrow under our credit facilities was $123.5 million and $98.3 million at September 30, 2023 and December 31, 2022, respectively, which was equal to the available amounts under the credit agreements of $125.0 million and $100.0 million, respectively, net of letters of credit of $1.5 million and $1.7 million, respectively. Our credit facilities contain certain customary financial and non-financial covenants. We were in compliance with all covenants as of September 30, 2023 and December 31, 2022.
Our future capital requirements may vary materially from those planned and will depend on certain factors, such as our growth and our operating results. If we require additional capital resources to grow our business or to acquire complementary technologies and businesses in the future, we may seek to sell additional equity or raise funds through debt financing or other sources. We cannot provide assurance that additional financing will be available at all or on terms favorable to us.
Sources and Uses of Capital Resources
The following table summarizes our cash flows:
(in millions)
| Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|
| Net cash provided by operating activities | $42.5 | $4.9 |
| Net cash used in investing activities | (20.1) | (94.3) |
| Net cash provided by (used in) financing activities | (19.8) | 60.3 |
| Effect of exchange rate changes on cash and cash equivalents | 0.1 | (0.3) |
| Net increase (decrease) in cash and cash equivalents | $2.7 | $(29.4) |
Operating activities
Net cash provided by operating activities increased $37.6 million in the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022, due to a $9.6 million decrease in net loss, a $20.8 million increase in non-cash charges, and a $7.2 million decrease in net cash outflow from changes in operating assets and liabilities. The increase in non-cash charges was primarily due to increases of $12.1 million in deferred taxes, $10.4 million in depreciation and amortization, and $4.0 million in stock-based compensation, partially offset by a $6.1 million change in fair value of contingent consideration related to earnouts for the nine months ended September 30, 2022. The decrease in net cash outflow from changes in operating assets and liabilities was primarily due to decreases of $20.3 million in accounts receivable, $11.6 million in accounts payable, and $4.4 million in other liabilities, substantially offset by increases of $21.8 million in accrued expenses and other current liabilities, $4.2 million in prepaid expenses and other assets, and $2.5 million for payments for contingent consideration in excess of the amounts recorded at the acquisition date.
Investing activities
Net cash used in investing activities decreased $74.2 million in the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022, primarily due to $69.5 million of cash paid, net of cash acquired, for our acquisition of OTB in the nine months ended September 30, 2022, as well as a $3.8 million decrease in purchases of property and equipment.
Financing activities
We had $19.8 million of net cash used in financing activities in the nine months ended September 30, 2023, as compared to $60.3 million of net cash provided by financing activities in the nine months ended September 30, 2022, primarily due to $70.0 million of proceeds from our line of credit to finance the cash portion of the purchase consideration for our acquisition of OTB in the nine months ended September 30, 2022. Additionally, $12.1 million for repurchases of Class A common stock in the nine months ended September 30, 2023 was partially offset by a $2.9 million increase from exercises of stock options and a $2.1 million decrease in payments for contingent consideration recorded at the acquisition date.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting policies as provided within U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates under different assumptions or conditions.
During the nine months ended September 30, 2023, there have been no material changes in our critical accounting policies as disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2022.
Market risk
As filed, 516 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates.
During the nine months ended September 30, 2023, there were no material changes from the market risk disclosures in our Annual Report on Form 10-K for the year ended December 31, 2022.
Controls and procedures
As filed, 1,091 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended). Management, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b) as of September 30, 2023. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls and procedures were effective as of September 30, 2023.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 538 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to risks and uncertainties in the ordinary course of business that are common to all businesses, important factors that are specific to our industry and the Company could have a material and adverse impact on our business, financial condition, results of operations and cash flows. You should carefully consider the risk factors set forth in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2022 and in our subsequent periodic filings with the Securities and Exchange Commission.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $152.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $465.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-07-01 to 2023-09-30 | $13.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-01-01 to 2023-09-30 | $40.2m | us-gaap:CostOfRevenue |
| Research and development | 3 months2023-07-01 to 2023-09-30 | $20.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-01-01 to 2023-09-30 | $60.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-07-01 to 2023-09-30 | $4.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-01-01 to 2023-09-30 | −$1.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-07-01 to 2023-09-30 | $200.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2023-01-01 to 2023-09-30 | $600.0k | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $5.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $10.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | −$500.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | −$9.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-01 to 2023-09-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-01 to 2023-09-30 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-01 to 2023-09-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-01 to 2023-09-30 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 77,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 76,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $42.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-01 to 2023-09-30 | $500.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-01-01 to 2023-09-30 | $12.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-30 | $86.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $194.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $420.8m | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $45.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $56.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-09-30 | $364.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001625278-23-000118. Last ingested by Listed: Nov 5, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.